medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 6

Next >>

Ann Hepatol 2016; 15 (6)

Hepatology highlights

Teschke R
Full text How to cite this article

Language: English
References: 7
Page: 812-814
PDF size: 115.85 Kb.


Key words:

No keywords

Text Extraction

Pawar SV, et al. Most overweight and obese Indian children have nonalcoholic fatty liver disease

Pawar SV, et al. The authors from Mumbai in India evaluated in their careful prospective school based cross sectional study a group of children in the age group from 11 to 15 years, measured their height and weight, and calculated the respective BMI. As expected, a liver biopsy as a gold standard to establish the diagnosis of NAFLD was not warranted, especially under the aspect of a clinical study and the risk of such invasive diagnostic procedure. Instead, the diagnosis of NAFLD was made by investigations used in daily clinical practice.


REFERENCES

  1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 205-23.

  2. Musso G, Gambino R, Cassader M, Pagano GA. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43; 617-49.

  3. Boyer TD, Haskal ZJ. AASLD Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Hepatology 2010; 51: 1-16.

  4. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplantant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288-95.

  5. Mendez-Sanchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobsahi-Margáin RA, et al. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol 20010; 9: 428-38.

  6. Mendez-Sanchez N, Aquilar-Ramírez RJ, Reyes A, Dehesa M, Juárez A, Castaneda B, Sánchez-Avila F, et al. Etiology of liver cirrhosis in Mexcio. Ann Hepatol 2004; 3: 30-3.

  7. AASLD/IDSA, HCV Guidance Panel. Hepatitis C Guidance: AASLD-IDSA reommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015; 62: 932-54.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2016;15